Biogen (BIIB) Gross Profit (2009 - 2026)
Biogen's Gross Profit was $1.96 billion in Q2 2026, down 4.0% from $2.04 billion a year earlier but up 7.8% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) Gross Profit (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Biogen's Gross Profit was $7.42 billion through Jun 30, 2026, down 1.6% year-over-year; for FY2025, it was $7.49 billion, up 1.6% from FY2024.
- Gross Profit shows a five-year compound annual growth rate of -8.4% (FY2020 to FY2025).
- In earlier years, Gross Profit was $7.37 billion in FY2024 (+0.9%), $7.3 billion in FY2023 (-7.5%), $7.9 billion in FY2022 (-11.0%) and $8.87 billion in FY2021 (-23.8%).
- Quarterly Gross Profit has moved between $1.75 billion (Q1 2024) and $2.27 billion (Q3 2021) over five years.
- Compared with a year earlier, Gross Profit was higher in five of the last eight quarters, with growth averaging 0.9%.
- The best year-over-year quarter for Gross Profit over five years was Q2 2025 (growth of 6.3%); the worst was Q3 2021 (a decline of 22.5%).
- Per Business Quant data, BIIB's Gross Profit in the three quarters before Q2 2026 was $1.82 billion (Q1 2026), $1.78 billion (Q4 2025) and $1.86 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Biogen | 37.52 Bn | 24.18 Bn | 1.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.96 Bn |
| Mar 31, 2026 | 1.82 Bn |
| Dec 31, 2025 | 1.78 Bn |
| Sep 30, 2025 | 1.86 Bn |
| Jun 30, 2025 | 2.04 Bn |
| Mar 31, 2025 | 1.80 Bn |
| Dec 31, 2024 | 1.87 Bn |
| Sep 30, 2024 | 1.83 Bn |
| Jun 30, 2024 | 1.92 Bn |
| Mar 31, 2024 | 1.75 Bn |
| Dec 31, 2023 | 1.77 Bn |
| Sep 30, 2023 | 1.87 Bn |
| Jun 30, 2023 | 1.86 Bn |
| Mar 31, 2023 | 1.80 Bn |
| Dec 31, 2022 | 1.97 Bn |
| Sep 30, 2022 | 2.04 Bn |
| Jun 30, 2022 | 2.11 Bn |
| Mar 31, 2022 | 1.78 Bn |
| Dec 31, 2021 | 2.07 Bn |
| Sep 30, 2021 | 2.27 Bn |
API Access
Biogen Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();